FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313492067> ?p ?o ?g. }

• W4313492067 endingPage "100573" @default.
• W4313492067 startingPage "100573" @default.
• W4313492067 abstract "Adding stereotactic radiosurgery (SRS) to combined immune checkpoint therapy with ipilimumab and nivolumab (IPI + NIVO) has led to promising results for patients with melanoma brain metastases (MBM). This study retrospectively analyzes the toxicity profile depending on the timing of SRS with regard to IPI + NIVO.For this study, the clinical database was searched for all patients with MBM who were treated with SRS and IPI + NIVO. The patients were separated into three groups: group A completed IPI + NIVO (usually up to four cycles) >14 days before SRS, in group B IPI + NIVO was initiated>14 days after SRS, and group C received SRS concurrently to IPI + NIVO. Treatment related toxicity was obtained from clinical and neuroradiological records. Analyses were performed using the Fisher-Yates-test.31 patients were assessed including six (19.4 %), seven (22.6 %) and 18 (58.1 %) patients, in groups A, B and C, respectively. Baseline prognostic markers between groups were balanced. In total, five (16.1 %) patients experienced neurological grade 3 toxicities related to SRS. All of these five patients were in group C, which was near-significantly correlated with a risk for grade 3 toxicities (p = 0.058). Post-hoc analyses showed that a maximum time period of seven days between SRS and IPI + NIVO was significantly correlated with grade 3 toxicity (p = 0.048).Application of SRS to IPI + NIVO within a seven-day span was related to higher toxicity rates in this retrospective analysis. After previous studies focused on immune checkpoint monotherapies with SRS and declared it as safe, this study indicates that concomitant application of IPI + NIVO and SRS might increase side effects. Prospective validation is warranted to corroborate these findings." @default.
• W4313492067 created "2023-01-06" @default.
• W4313492067 creator A5004348810 @default.
• W4313492067 creator A5004434507 @default.
• W4313492067 creator A5004991123 @default.
• W4313492067 creator A5008568372 @default.
• W4313492067 creator A5011416942 @default.
• W4313492067 creator A5022915996 @default.
• W4313492067 creator A5038323479 @default.
• W4313492067 creator A5039732735 @default.
• W4313492067 creator A5059390129 @default.
• W4313492067 creator A5065547065 @default.
• W4313492067 creator A5073727799 @default.
• W4313492067 creator A5076352856 @default.
• W4313492067 creator A5086657546 @default.
• W4313492067 creator A5088772306 @default.
• W4313492067 date "2023-03-01" @default.
• W4313492067 modified "2023-10-01" @default.
• W4313492067 title "Stereotactic radiosurgery and combined immune checkpoint therapy with ipilimumab and nivolumab in patients with melanoma brain metastases: A retrospective monocentric toxicity analysis" @default.
• W4313492067 cites W1642085743 @default.
• W4313492067 cites W2061733422 @default.
• W4313492067 cites W2074933858 @default.
• W4313492067 cites W2097995306 @default.
• W4313492067 cites W2128035403 @default.
• W4313492067 cites W2152897456 @default.
• W4313492067 cites W2326574449 @default.
• W4313492067 cites W2476838381 @default.
• W4313492067 cites W2525304626 @default.
• W4313492067 cites W2560367415 @default.
• W4313492067 cites W2569790571 @default.
• W4313492067 cites W2573323145 @default.
• W4313492067 cites W2753432434 @default.
• W4313492067 cites W2781991155 @default.
• W4313492067 cites W2794627893 @default.
• W4313492067 cites W2802488938 @default.
• W4313492067 cites W2884665344 @default.
• W4313492067 cites W2888298425 @default.
• W4313492067 cites W2892179556 @default.
• W4313492067 cites W2896600825 @default.
• W4313492067 cites W2944589699 @default.
• W4313492067 cites W2947333020 @default.
• W4313492067 cites W3010353587 @default.
• W4313492067 cites W3013320481 @default.
• W4313492067 cites W3018862202 @default.
• W4313492067 cites W3034586201 @default.
• W4313492067 cites W3043703771 @default.
• W4313492067 cites W3086541801 @default.
• W4313492067 cites W3089951509 @default.
• W4313492067 cites W3161389086 @default.
• W4313492067 cites W4225947493 @default.
• W4313492067 cites W4226258201 @default.
• W4313492067 cites W4226373240 @default.
• W4313492067 cites W2510327585 @default.
• W4313492067 doi "https://doi.org/10.1016/j.ctro.2022.100573" @default.
• W4313492067 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36655118" @default.
• W4313492067 hasPublicationYear "2023" @default.
• W4313492067 type Work @default.
• W4313492067 citedByCount "1" @default.
• W4313492067 countsByYear W43134920672023 @default.
• W4313492067 crossrefType "journal-article" @default.
• W4313492067 hasAuthorship W4313492067A5004348810 @default.
• W4313492067 hasAuthorship W4313492067A5004434507 @default.
• W4313492067 hasAuthorship W4313492067A5004991123 @default.
• W4313492067 hasAuthorship W4313492067A5008568372 @default.
• W4313492067 hasAuthorship W4313492067A5011416942 @default.
• W4313492067 hasAuthorship W4313492067A5022915996 @default.
• W4313492067 hasAuthorship W4313492067A5038323479 @default.
• W4313492067 hasAuthorship W4313492067A5039732735 @default.
• W4313492067 hasAuthorship W4313492067A5059390129 @default.
• W4313492067 hasAuthorship W4313492067A5065547065 @default.
• W4313492067 hasAuthorship W4313492067A5073727799 @default.
• W4313492067 hasAuthorship W4313492067A5076352856 @default.
• W4313492067 hasAuthorship W4313492067A5086657546 @default.
• W4313492067 hasAuthorship W4313492067A5088772306 @default.
• W4313492067 hasBestOaLocation W43134920671 @default.
• W4313492067 hasConcept C121608353 @default.
• W4313492067 hasConcept C126322002 @default.
• W4313492067 hasConcept C143998085 @default.
• W4313492067 hasConcept C167135981 @default.
• W4313492067 hasConcept C2777658100 @default.
• W4313492067 hasConcept C2777701055 @default.
• W4313492067 hasConcept C2780030458 @default.
• W4313492067 hasConcept C2780387249 @default.
• W4313492067 hasConcept C2781433595 @default.
• W4313492067 hasConcept C29730261 @default.
• W4313492067 hasConcept C502942594 @default.
• W4313492067 hasConcept C509974204 @default.
• W4313492067 hasConcept C67761136 @default.
• W4313492067 hasConcept C71924100 @default.
• W4313492067 hasConceptScore W4313492067C121608353 @default.
• W4313492067 hasConceptScore W4313492067C126322002 @default.
• W4313492067 hasConceptScore W4313492067C143998085 @default.
• W4313492067 hasConceptScore W4313492067C167135981 @default.
• W4313492067 hasConceptScore W4313492067C2777658100 @default.
• W4313492067 hasConceptScore W4313492067C2777701055 @default.
• W4313492067 hasConceptScore W4313492067C2780030458 @default.
• W4313492067 hasConceptScore W4313492067C2780387249 @default.
• W4313492067 hasConceptScore W4313492067C2781433595 @default.

• next